Showing 9 of 29 recruiting trials for “Aggressive B-cell non-Hodgkin lymphoma”
Acalabrutinib in Combination With R-miniCHOP in Older Adults With Untreated Diffuse Large B-Cell Lymphoma
👨⚕️ Konstantinos Christofyllakis, MD MSc, Saarland University Medical Center📍 17 sites📅 Started Jun 2023View details ↗
Study of LYL314 in Aggressive Large B-Cell Lymphoma
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Mosunetuzumab Consolidation Therapy After autoSCT in r/r Aggressive B Cell Lymphoma
👨⚕️ Armin Ghobadi, M.D., Washington University School of Medicine📍 1 site📅 Started Dec 2022View details ↗
Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia
Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma
Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma
👨⚕️ Ryan Lynch, Fred Hutch/University of Washington Cancer Consortium📍 1 site📅 Started Oct 2020View details ↗
Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma
👨⚕️ Sarit Assouline, The Jewish General Hospital, Montreal QC, Canada📍 4 sites📅 Started Sep 2020View details ↗
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
← PreviousPage 2 of 2
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →